share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

SEC ·  Jun 26 04:18
Summary by Futu AI
James F. Young, associated with Novavax Inc [NVAX], completed a sale of 7,500 shares of common stock on June 21, 2024. The transaction was carried out in the open market with the shares sold at a price of $14.09 each, resulting in a total sale value of $105,675. Following the sale, Young's direct holdings in Novavax common stock amount to 61,760 shares.
James F. Young, associated with Novavax Inc [NVAX], completed a sale of 7,500 shares of common stock on June 21, 2024. The transaction was carried out in the open market with the shares sold at a price of $14.09 each, resulting in a total sale value of $105,675. Following the sale, Young's direct holdings in Novavax common stock amount to 61,760 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.